Bios Fund Ii, Lp - Net Worth and Insider Trading
Bios Fund Ii, Lp Net Worth
The estimated net worth of Bios Fund Ii, Lp is at least $1 Million dollars as of 2024-05-09. Bios Fund Ii, Lp is the Director, 10% Owner of IN8bio Inc and owns about 997,433 shares of IN8bio Inc (INAB) stock worth over $1 Million. Details can be seen in Bios Fund Ii, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bios Fund Ii, Lp has not made any transactions after 2022-12-12 and currently still holds the listed stock(s).
Transaction Summary of Bios Fund Ii, Lp
Bios Fund Ii, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bios Fund Ii, Lp owns 4 companies in total, including Lantern Pharma Inc (LTRN) , Cognition Therapeutics Inc (CGTX) , and IN8bio Inc (INAB) among others .
Click here to see the complete history of Bios Fund Ii, Lp’s form 4 insider trades.
Insider Ownership Summary of Bios Fund Ii, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2022-09-02 | 10 percent owner |
| CGTX | Cognition Therapeutics Inc | 2022-11-15 | 10 percent owner |
| INAB | IN8bio Inc | 2022-12-12 | director & 10 percent owner |
 | | 2023-06-15 | 10 percent owner |
Bios Fund Ii, Lp Latest Holdings Summary
Bios Fund Ii, Lp currently owns a total of 1 stock. Bios Fund Ii, Lp owns 997,433 shares of IN8bio Inc (INAB) as of December 12, 2022, with a value of $1 Million.
Latest Holdings of Bios Fund Ii, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INAB | IN8bio Inc | 2022-12-12 | 997,433 | 1.01 | 1,007,407 |
Holding Weightings of Bios Fund Ii, Lp
Bios Fund Ii, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Bios Fund Ii, Lp has made a total of 2 transactions in IN8bio Inc (INAB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 75,001 shares on December 12, 2022, which cost Bios Fund Ii, Lp around $186,002.
Insider Trading History of Bios Fund Ii, Lp
- 1
Bios Fund Ii, Lp Trading Performance
GuruFocus tracks the stock performance after each of Bios Fund Ii, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bios Fund Ii, Lp is -22.39%. GuruFocus also compares Bios Fund Ii, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bios Fund Ii, Lp within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bios Fund Ii, Lp's insider trading performs compared to the benchmark.
Performance of Bios Fund Ii, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10 | | | | | |
| Relative Return to S&P 500(%) | -12.35 | | | | | |
Bios Fund Ii, Lp Ownership Network
Bios Fund Ii, Lp Owned Company Details
What does Lantern Pharma Inc do?
Who are the key executives at Lantern Pharma Inc?
Bios Fund Ii, Lp is the 10 percent owner of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Bios Fund I, Lp , and 10 percent owner Fletcher Aaron G.l. .
Lantern Pharma Inc (LTRN) Insider Trades Summary
Over the past 18 months, Bios Fund Ii, Lp made no insider transaction in Lantern Pharma Inc (LTRN). Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 348,237 shares made by Leslie W. Kreis , and a net sale of 348,237 shares made by Bios Fund I, Lp .
In summary, during the past 3 months, insiders sold 288,000 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 288,000 shares. During the past 18 months, 696,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 696,474 shares.
Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lantern Pharma Inc Insider Transactions
Bios Fund Ii, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Bios Fund Ii, Lp. You might contact Bios Fund Ii, Lp via mailing address: 1401 Foch Street, Suite 140, Fort Worth Tx 76107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
